Literature DB >> 2242457

Prevalence of symptoms of Raynaud's phenomenon in general practice.

A Silman1, S Holligan, P Brennan, P Maddison.   

Abstract

OBJECTIVE: To investigate the prevalence of Raynaud's phenomenon in the populations of five general practices.
DESIGN: Two populations studied. A questionnaire was given to all new patients attending five general practices over four weeks, and the same questionnaire was sent by post to a random sample of adults from two of the practices.
SETTING: General practices in inner London, Merseyside, and Cheshire.
SUBJECTS: 1532 Patients who completed questionnaires (1119 who attended the surgeries (response rate unknown) and 413 respondents to the postal survey (response rate 69%)). MAIN OUTCOME MEASURES: Response to questionnaire on symptoms of Raynaud's phenomenon: patients were regarded as having the disease if they had episodes of blanching of the fingers that were precipitated by cold and accompanied by sensory symptoms (pins and needles or numbness). Subsequent interview and clinical appraisal of patients with the disease according to their responses to the questionnaire.
RESULTS: The prevalence of Raynaud's phenomenon was 11% (26/231) and 19% (34/182) respectively in men and women who completed the postal questionnaire and 16% (56/357) and 21% (157/762) respectively in those who completed the questionnaire when attending their general practice. Thus the overall rates were slightly higher in women, but there was no effect of age even after adjustment of the rates for practice and method of survey.
CONCLUSION: The prevalence of Raynaud's phenomenon is high compared with the low number of patients who seek treatment for the disease.

Entities:  

Mesh:

Year:  1990        PMID: 2242457      PMCID: PMC1663723          DOI: 10.1136/bmj.301.6752.590

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  8 in total

1.  Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire.

Authors:  H R Maricq; M C Weinrich; J E Keil; E C LeRoy
Journal:  J Chronic Dis       Date:  1986

2.  Diagnosis of Raynaud's phenomenon assisted by color charts.

Authors:  H R Maricq; M C Weinrich
Journal:  J Rheumatol       Date:  1988-03       Impact factor: 4.666

3.  Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.

Authors:  D D Gerbracht; V D Steen; G L Ziegler; T A Medsger; G P Rodnan
Journal:  Arthritis Rheum       Date:  1985-01

4.  A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report.

Authors:  F E Harper; H R Maricq; R E Turner; R W Lidman; E C Leroy
Journal:  Am J Med       Date:  1982-06       Impact factor: 4.965

5.  Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.

Authors:  C G Kallenberg; A A Wouda; M H Hoet; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

6.  Prospective study of the evolution of Raynaud's phenomenon.

Authors:  O Fitzgerald; E V Hess; G T O'Connor; G Spencer-Green
Journal:  Am J Med       Date:  1988-04       Impact factor: 4.965

7.  An epidemiological survey of Raynaud's phenomenon.

Authors:  J C de Trafford; K Lafferty; C E Potter; V C Roberts; L T Cotton
Journal:  Eur J Vasc Surg       Date:  1988-06

8.  Raynaud's disease among women and girls.

Authors:  R W GIFFORD; E A HINES
Journal:  Circulation       Date:  1957-12       Impact factor: 29.690

  8 in total
  29 in total

Review 1.  Raynaud's phenomenon: epidemiology and risk factors.

Authors:  Liana Fraenkel
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

Review 2.  The pathogenesis, diagnosis and treatment of Raynaud phenomenon.

Authors:  Ariane L Herrick
Journal:  Nat Rev Rheumatol       Date:  2012-07-10       Impact factor: 20.543

3.  Prevalence of Raynaud's phenomenon in a healthy Greek population.

Authors:  P V Voulgari; Y Alamanos; D Papazisi; K Christou; C Papanikolaou; A A Drosos
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

4.  Primary care assessment of capillaroscopy abnormalities in patients with Raynaud's phenomenon.

Authors:  Rebecca Overbury; Maureen A Murtaugh; Aryeh Fischer; Tracy M Frech
Journal:  Clin Rheumatol       Date:  2015-09-23       Impact factor: 2.980

5.  To compare the efficacy and safety of nifedipine sustained release with Ginkgo biloba extract to treat patients with primary Raynaud's phenomenon in South Korea; Korean Raynaud study (KOARA study).

Authors:  Whan-Seok Choi; Chang-Jin Choi; Kyung-Soo Kim; Jae-Ho Lee; Chan-Hee Song; Ju-Hye Chung; Sun-Myeoung Ock; Jung-Bok Lee; Chul-Min Kim
Journal:  Clin Rheumatol       Date:  2009-01-22       Impact factor: 2.980

6.  Raynaud's phenomenon and vitamin D.

Authors:  Josiane Hélou; Roy Moutran; Ismael Maatouk; Fady Haddad
Journal:  Rheumatol Int       Date:  2012-05-12       Impact factor: 2.631

7.  Raynaud's phenomenon: prevalence in an Italian population sample.

Authors:  Rossella De Angelis; Fausto Salaffi; Walter Grassi
Journal:  Clin Rheumatol       Date:  2005-11-15       Impact factor: 2.980

8.  Symptoms of hand-arm vibration syndrome in gas distribution operatives.

Authors:  K Palmer; G Crane; H Inskip
Journal:  Occup Environ Med       Date:  1998-10       Impact factor: 4.402

Review 9.  Management of Raynaud's phenomenon and digital ischemia.

Authors:  Ariane L Herrick
Journal:  Curr Rheumatol Rep       Date:  2013-01       Impact factor: 4.592

10.  Paraneoplastic Raynaud's phenomenon in a breast cancer survivor.

Authors:  David Allen; David Robinson; Shikha Mittoo
Journal:  Rheumatol Int       Date:  2009-06-11       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.